AdAlta Limited Profile Avatar - Palmy Investing

AdAlta Limited

AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein therapeutics in Australia. The company's lead i-body drug candidate includes AD-214, which is in Phase I clinical trials for the treatment of idiopathic pulmonary fibr…

Biotechnology
AU, Melbourne [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of 1AD.AX's Analysis
CIK: - CUSIP: Q0101X107 ISIN: AU0000001AD2 LEI: - UEI: -
Secondary Listings
1AD.AX has no secondary listings inside our databases.